Patterns of treatment effects in subsets of patients in clinical trials
From MaRDI portal
Publication:5701276
Recommendations
- Bayesian Subset Analysis
- scientific article; zbMATH DE number 124958
- Detecting an interaction between treatment and a continuous covariate: a comparison of two approaches
- Testing for Qualitative Interactions between Treatment Effects and Patient Subsets
- Confidence regions for treatment effects in subgroups in biomarker stratified designs
Cited in
(28)- A simple method for estimating interactions between a treatment and a large number of covariates
- Personalized treatment selection via the covariate-specific treatment effect curve for longitudinal data
- Effectively Selecting a Target Population for a Future Comparative Study
- A simulation study comparing different statistical approaches for the identification of predictive biomarkers
- Focused information criterion on predictive models in personalized medicine
- Analysis of randomized comparative clinical trial data for personalized treatment selections
- Adaptive enrichment designs with a continuous biomarker
- Assessing heterogeneity in surrogacy using censored data
- Subgroup analysis with a nonparametric unimodal symmetric error distribution
- Augmented direct learning for conditional average treatment effect estimation with double robustness
- Detecting an interaction between treatment and a continuous covariate: a comparison of two approaches
- Treatment effect heterogeneity for univariate subgroups in clinical trials: shrinkage, standardization, or else
- Confidence regions for treatment effects in subgroups in biomarker stratified designs
- A tutorial on interaction
- Addressing patient heterogeneity in disease predictive model development
- Change-Plane Analysis for Subgroup Detection with a Continuous Treatment
- Investigation of age-treatment interaction in the SPACE trial using different statistical approaches
- Covariate-adjusted response-adaptive designs for generalized linear models
- BATE curve in assessment of clinical utility of predictive biomarkers
- Subgroup analysis with time-to-event data under a logistic-Cox mixture model
- Estimation and visualization of heterogeneous treatment effects for multiple outcomes
- Responder identification in clinical trials with censored data
- Subject-treatment interactions in crossover trials: performance evaluation of subgrouping methods
- An approach to evaluating and comparing biomarkers for patient treatment selection
- Evaluating marker-guided treatment selection strategies
- REPRESENTING THE RESULTS OF SUBGROUP ANALYSIS IN COMPARATIVE CLINICAL STUDIES BY A GRAPH
- Bayesian tree-based heterogeneous mediation analysis with a time-to-event outcome
- Case-Only Analysis of Treatment-Covariate Interactions in Clinical Trials
This page was built for publication: Patterns of treatment effects in subsets of patients in clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5701276)
